Sunzen Biotech to acquire 70% of ophthalmic products company Eye Nation

Sunzen Biotech Bhd has entered into a share sale agreement with Lee Peng Hwa and Lay Lee Chin for the acquisition of 70,000 ordinary shares, representing 70% of the equity interest of Eye Nation Medical Sdn Bhd for a total cash consideration of RM6.37 million.

Eye Nation was incorporated in Malaysia on Nov 6, 2003 as a private limited company. Its principal activity is trading in diagnostic equipment and related products in the ophthalmic industry. Pursuant to the acquisition, the vendors have Eye Nation’s audited profit after tax for the financial period from July 1, 2024 to June 30, 2025 shall not be less than RM1.3 million; and audited profit after tax for the financial period from July 1, 2025 to June 30, 2026 also shall not be less than RM1.3 million.

الإمارات العربية المتحدة أحدث الأخبار, الإمارات العربية المتحدة عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Sunzen Biotech eyes bigger share of China bird’s nest marketKUALA LUMPUR: Sunzen Biotech Bhd will engage with relevant government agencies in the next few months to increase the bird’s nest harvesting quota and...
مصدر: theSundaily - 🏆 25. / 51 اقرأ أكثر »